查詢結果分析
相關文獻
- 罕見疾病(先天代謝疾病)新生兒篩檢政策之探討--篩檢原則與父母醫療決定權之衡平
- Newborn Screening for Methylmalonic Aciduria by Tandem Mass Spectrometry: 7 Years' Experience From Two Centers in Taiwan
- 新生兒篩檢
- Intellectual Outcomes of Patients with Congenital Hypothyroidism Not Detected by Neonatal Screening
- 誰來同意?誰作決定?--從「告知後同意法則」談病人自主權的理論與實際:美國經驗之考察
- 液相層析串聯質譜儀於結構分析之應用
- 罕見疾病相關機構之標誌研究
- Intellectual Outcome of Patients with Congenital Hypothyroidism Detected by Neonatal Screening
- 以液相層析串聯質譜儀檢測肉品中殘留合成抗菌劑
- A Pilot Study of Neonatal Screening by Electrospray Ionization Tandem Mass Spectrometry in Taiwan
頁籤選單縮合
題名 | 罕見疾病(先天代謝疾病)新生兒篩檢政策之探討--篩檢原則與父母醫療決定權之衡平=Newborn Baby Screening for Rare Disease: Children's Best Interest and the Parental Right of Decision |
---|---|
作者 | 劉兆菊; | 書刊名 | 科技法學評論 |
卷期 | 5:2 2008.10[民97.10] |
頁次 | 頁255-286 |
分類號 | 417.509 |
關鍵詞 | 新生兒篩檢; 罕見疾病; 串聯質譜儀; 醫療決定權; 子女之最佳利益; 篩檢原則; 告知後同意; Newborn baby screening; Rare disease; Tandem mass spectrometery; Medical decision right; Children's best benefit; Screening principle; Informed consent; |
語文 | 中文(Chinese) |